Page last updated: 2024-08-24

goralatide and Renal Insufficiency

goralatide has been researched along with Renal Insufficiency in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borkum, MS; Engel, ME; Mayosi, BM; Mnguni, AT	1
Hino, T; Ikemura, A; Inoue, K; Oka, H; Tsuruta, Y; Tsutsumiuchi, K; Watanabe, K	1
Araki, S; Haneda, M; Isono, M; Isshiki, K; Kanasaki, K; Kashiwagi, A; Koya, D; Omata, M; Sato, H; Shibuya, K; Sugimoto, T	1

Reviews

1 review(s) available for goralatide and Renal Insufficiency

Article	Year
The Effects of Angiotensin Converting Enzyme Inhibitors (ACE-I) on Human N-Acetyl-Seryl-Aspartyl-Lysyl-Proline (Ac-SDKP) Levels: A Systematic Review and Meta-Analysis. PloS one, 2015, Volume: 10, Issue:12 Topics: Angiotensin-Converting Enzyme Inhibitors; Fibrosis; Humans; Myocardium; Oligopeptides; Patient Selection; Pericarditis, Tuberculous; Prospective Studies; Renal Insufficiency	2015

Other Studies

2 other study(ies) available for goralatide and Renal Insufficiency

Article	Year
Quantification of N-acetyl-seryl-aspartyl-lysyl-proline in hemodialysis patients administered angiotensin-converting enzyme inhibitors by stable isotope dilution liquid chromatography-tandem mass spectrometry. Journal of pharmaceutical and biomedical analysis, 2011, Mar-25, Volume: 54, Issue:4 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Carbon Isotopes; Chromatography, High Pressure Liquid; Deuterium; Drug Monitoring; Female; Humans; Hypertension; Indicator Dilution Techniques; Male; Middle Aged; Nitrogen Isotopes; Oligopeptides; Peptide Fragments; Renal Dialysis; Renal Insufficiency; Solid Phase Extraction; Tandem Mass Spectrometry; Thymosin	2011
N-acetyl-seryl-aspartyl-lysyl-proline prevents renal insufficiency and mesangial matrix expansion in diabetic db/db mice. Diabetes, 2005, Volume: 54, Issue:3 Topics: Animals; Collagen Type IV; Diabetic Nephropathies; DNA-Binding Proteins; Extracellular Matrix Proteins; Fibronectins; Gene Expression; Glomerular Mesangium; Male; Mice; Mice, Knockout; Oligopeptides; Renal Insufficiency; Smad3 Protein; Trans-Activators; Transforming Growth Factor beta	2005

Article

Year

Quantification of N-acetyl-seryl-aspartyl-lysyl-proline in hemodialysis patients administered angiotensin-converting enzyme inhibitors by stable isotope dilution liquid chromatography-tandem mass spectrometry.

Journal of pharmaceutical and biomedical analysis, 2011, Mar-25, Volume: 54, Issue:4

Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Carbon Isotopes; Chromatography, High Pressure Liquid; Deuterium; Drug Monitoring; Female; Humans; Hypertension; Indicator Dilution Techniques; Male; Middle Aged; Nitrogen Isotopes; Oligopeptides; Peptide Fragments; Renal Dialysis; Renal Insufficiency; Solid Phase Extraction; Tandem Mass Spectrometry; Thymosin

2011

N-acetyl-seryl-aspartyl-lysyl-proline prevents renal insufficiency and mesangial matrix expansion in diabetic db/db mice.

Diabetes, 2005, Volume: 54, Issue:3

Topics: Animals; Collagen Type IV; Diabetic Nephropathies; DNA-Binding Proteins; Extracellular Matrix Proteins; Fibronectins; Gene Expression; Glomerular Mesangium; Male; Mice; Mice, Knockout; Oligopeptides; Renal Insufficiency; Smad3 Protein; Trans-Activators; Transforming Growth Factor beta

2005